WASHINGTON, D.C. — Following the U.S. Presidential Election being called for Former President Donald Trump, David Mitchell, Founder of Patients For Affordable Drugs Now, issued the following statement:
“Patients For Affordable Drugs Now remains unwavering in our mission to lower drug prices for millions of Americans and we are ready to work with President-Elect Trump and the new Congress to make prescription drugs more affordable for those facing crushing costs.
“Even with the sweeping reforms ushered in under the Biden-Harris administration, one in three Americans still can’t afford their prescription drugs, and nine in ten agree that lowering drug prices should be a top priority for our elected leaders. On behalf of patients across all 50 states, we are committed to working with the Trump-Vance administration and the new Congress to expand on the gains made in recent years to lower drug prices and continue to deliver meaningful relief to patients.
“Previously, President-Elect Trump voiced support for allowing Medicare to negotiate lower prices and implementing the ‘Most Favored Nation’ model to prevent Americans from paying more than the average prices people in other countries pay for the same medications. We are hopeful that the new administration will return to these commitments or bring forward other approaches we can help enact to build upon the progress achieved in recent years.
“The Inflation Reduction Act was the most significant step forward in lowering prescription drug prices in two decades. On behalf of the patients we represent, we will vigorously defend the landmark drug pricing law against any attempts to roll back these hard-won reforms – whether through administrative action, legislation, or litigation.
“As a bipartisan organization, we know that lowering drug prices isn’t a Democratic or Republican issue – the pain of high drug prices is not limited to a single party. More than 80 percent of Americans support the principal reforms we champion. We will bring our voices to bear to keep what we have won. But we will support the new administration as it works to rein in the unchecked pricing power of drug companies, the practices of PBMs that put profits ahead of patients, and make prescription drugs affordable for every person in the U.S.”
###
Patients for Affordable Drugs Now, is the only national, patient advocacy organization focused exclusively on policies to lower drug prices. We empower and mobilize patients and allies, hold accountable those in power, and fight to shape and achieve system-changing policies that make prescription drugs affordable for all people in the United States. P4ADNow is bipartisan and does not accept funding from organizations that profit from the development or distribution of prescription drugs. To learn more visit PatientsForAffordableDrugsNOW.org.